BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williamson ED, Westlake GE. Vaccines for emerging pathogens: prospects for licensure. Clin Exp Immunol 2019;198:170-83. [PMID: 30972733 DOI: 10.1111/cei.13284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Williamson ED. Vaccines for emerging pathogens: from research to the clinic. Part two. Clin Exp Immunol 2019;198:141-2. [PMID: 31625155 DOI: 10.1111/cei.13378] [Reference Citation Analysis]
2 Oñate AA, Wan Y, Moreno A. Editorial: Molecular Vaccines Against Pathogens in the Post-genomic Era. Front Cell Infect Microbiol 2019;9:443. [PMID: 32039041 DOI: 10.3389/fcimb.2019.00443] [Reference Citation Analysis]
3 Matz KM, Marzi A, Feldmann H. Ebola vaccine trials: progress in vaccine safety and immunogenicity. Expert Rev Vaccines 2019;18:1229-42. [PMID: 31779496 DOI: 10.1080/14760584.2019.1698952] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
4 Moore BD, Macleod C, Henning L, Krile R, Chou Y, Laws TR, Butcher WA, Moore KM, Walker NJ, Williamson ED, Galloway DR. Predictors of Survival after Vaccination in a Pneumonic Plague Model. Vaccines 2022;10:145. [DOI: 10.3390/vaccines10020145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 van Oosterwijk JG. Anti-tick and pathogen transmission blocking vaccines. Parasite Immunol 2021;43:e12831. [PMID: 33704804 DOI: 10.1111/pim.12831] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hidalgo-simon A, Botgros R, Cochino E. Authorization of Vaccines in the European Union. Mol Front J 2021;05:58-65. [DOI: 10.1142/s2529732521400034] [Reference Citation Analysis]